Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 183

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Matrix metalloproteinases: The sculptors of chronic cutaneous wounds

Open access
Krishnaswamy, Venkat Raghavan, Mintz, Dvir, Sagi, Irit · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbamcr.2017.08.003

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 116

  1. Diegelmann, 2004, Wound healing: an overview of acute, fibrotic and delayed healing, Front. Biol., 9, 283
  2. Shaw, 2009, Wound repair at a glance, J. Cell Sci., 122, 3209, 10.1242/jcs.031187 · DOI · Paper page
  3. Yamaguchi, 2001, Cutaneous wound healing: an update, J. Dermatol., 28, 521, 10.1111/j.1346-8138.2001.tb00025.x · DOI · Paper page
  4. Martin, 1997, Wound healing—aiming for perfect skin regeneration, Science, 276, 75, 10.1126/science.276.5309.75 · DOI · Paper page
  5. Schultz, 2011, Dynamic reciprocity in the wound microenvironment, Wound Repair Regen., 19, 134, 10.1111/j.1524-475X.2011.00673.x · DOI · Paper page
  6. Cooper, 2002, The biology of the skin, J. R. Soc. Med., 95, 109, 10.1177/014107680209500221 · doi:10.1177/014107680209500221
  7. Gross, 1962, Collagenolytic activity in amphibian tissues: a tissue culture assay, Proc. Natl. Acad. Sci. U. S. A., 48, 1014, 10.1073/pnas.48.6.1014 · DOI · Paper page
  8. Puente, 2003, Human and mouse proteases: a comparative genomic approach, Nature reviews., Genetics, 4, 544
  9. Fanjul-Fernandez, 2010, Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models, Biochim. Biophys. Acta, 1803, 3, 10.1016/j.bbamcr.2009.07.004 · DOI · Paper page
  10. Levi, 1996, Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1, Proc. Natl. Acad. Sci. U. S. A., 93, 7069, 10.1073/pnas.93.14.7069 · DOI · Paper page
  11. Preece, 1996, Metalloproteinase-mediated regulation of l-selectin levels on leucocytes, J. Biol. Chem., 271, 11634, 10.1074/jbc.271.20.11634 · DOI · Paper page
  12. Suzuki, 1997, Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site, J. Biol. Chem., 272, 31730, 10.1074/jbc.272.50.31730 · DOI · Paper page
  13. Rundhaug, 2005, Matrix metalloproteinases and angiogenesis, J. Cell. Mol. Med., 9, 267, 10.1111/j.1582-4934.2005.tb00355.x · DOI · Paper page
  14. Solomonov, 2016, Distinct biological events generated by ECM proteolysis by two homologous collagenases, Proc. Natl. Acad. Sci. U. S. A., 113, 10884, 10.1073/pnas.1519676113 · DOI
  15. Chen, 2013, Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling, Mediat. Inflamm., 2013, 928315, 10.1155/2013/928315 · DOI · Paper page
  16. Brennan, 2006, Antibacterial activity within degradation products of biological scaffolds composed of extracellular matrix, Tissue Eng., 12, 2949, 10.1089/ten.2006.12.2949 · DOI · Paper page
  17. Suleman, 2016, Extracellular bacterial proteases in chronic wounds: a potential therapeutic target?, Adv. Wound Care, 5, 455, 10.1089/wound.2015.0673 · DOI
  18. Maeda, 1989, Pathogenic potentials of bacterial proteases, Clin. Chim. Acta, 185, 357, 10.1016/0009-8981(89)90226-X · doi:10.1016/0009-8981(89)90226-x
  19. Wong, 2011, S1 pocket of a bacterially derived subtilisin-like protease underpins effective tissue destruction, J. Biol. Chem., 286, 42180, 10.1074/jbc.M111.298711 · DOI
  20. Ravanti, 2000, Matrix metalloproteinases in wound repair (review), Int. J. Mol. Med., 6, 391
  21. Steffensen, 2001, Proteolytic events of wound-healing—coordinated interactions among matrix metalloproteinases (MMPs), integrins, and extracellular matrix molecules, Crit. Rev. Oral Biol. Med., 12, 373, 10.1177/10454411010120050201 · DOI · Paper page
  22. Lähteenmäki, 1998, Expression of plasminogen activator Pla of Yersinia pestis enhances bacterial attachment to the mammalian extracellular matrix, Infect. Immun., 66, 5755, 10.1128/IAI.66.12.5755-5762.1998 · DOI
  23. Stevens, 2014, Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America, Clin. Infect. Dis., ciu296
  24. McMenemy, 2017, Skin and soft tissue infections, Phys. Assist. Clin., 2, 165
  25. Cooper, 1996, The isolation and identification of bacteria from wounds, J. Wound Care, 5, 335, 10.12968/jowc.1996.5.7.335 · doi:10.12968/jowc.1996.5.7.335
  26. Bessa, 2015, Bacterial isolates from infected wounds and their antibiotic susceptibility pattern: some remarks about wound infection, Int. Wound J., 12, 47, 10.1111/iwj.12049 · DOI · Paper page
  27. Flemming, 2010, The biofilm matrix, Nat. Rev. Microbiol., 8, 623, 10.1038/nrmicro2415 · DOI · Paper page
  28. Metcalf, 2013, Biofilm delays wound healing: a review of the evidence, Burns Trauma, 1, 5, 10.4103/2321-3868.113329 · DOI · Paper page
  29. Attinger, 2012, Clinically addressing biofilm in chronic wounds, Adv. Wound Care, 1, 127, 10.1089/wound.2011.0333 · DOI · Paper page
  30. Davies, 2007, A prospective study of the microbiology of chronic venous leg ulcers to reevaluate the clinical predictive value of tissue biopsies and swabs, Wound Repair Regen., 15, 17, 10.1111/j.1524-475X.2006.00180.x · DOI
  31. Dowd, 2008, Survey of bacterial diversity in chronic wounds using pyrosequencing, DGGE, and full ribosome shotgun sequencing, BMC Microbiol., 8, 43, 10.1186/1471-2180-8-43 · DOI · Paper page
  32. Rayment, 2009, Review: finding the culprit: a review of the influences of proteases on the chronic wound environment, Int. J. Lower Extrem. Wounds, 8, 19, 10.1177/1534734609331596 · DOI
  33. Trengove, 1999, Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors, Wound Repair Regen., 7, 442, 10.1046/j.1524-475X.1999.00442.x · DOI · Paper page
  34. Shapiro, 1998, Matrix metalloproteinase degradation of extracellular matrix: biological consequences, Curr. Opin. Cell Biol., 10, 602, 10.1016/S0955-0674(98)80035-5 · DOI · Paper page
  35. Yue, 2012, Role of integrins in regulating proteases to mediate extracellular matrix remodeling, Cancer Microenviron., 5, 275, 10.1007/s12307-012-0101-3 · DOI
  36. Kryczka, 2012, Matrix metalloproteinase-2 cleavage of the beta1 integrin ectodomain facilitates colon cancer cell motility, J. Biol. Chem., 287, 36556, 10.1074/jbc.M112.384909 · DOI
  37. Armstrong, 2002, The role of matrix metalloproteinases in wound healing, J. Am. Podiatr. Med. Assoc., 92, 12, 10.7547/87507315-92-1-12 · DOI · Paper page
  38. Ren, 2014, Role of matrix metalloproteinases in chronic wound healing: diagnostic and therapeutic implications, Chin. Med. J., 127, 1572, 10.3760/cma.j.issn.0366-6999.20131179 · DOI
  39. Lobmann, 2002, Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients, Diabetologia, 45, 1011, 10.1007/s00125-002-0868-8 · DOI · Paper page
  40. Bullen, 1995, Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds, J. Invest. Dermatol., 104, 236, 10.1111/1523-1747.ep12612786 · DOI · Paper page
  41. Schultz, 2009, Interactions between extracellular matrix and growth factors in wound healing, Wound Repair Regen., 17, 153, 10.1111/j.1524-475X.2009.00466.x · DOI · Paper page
  42. Krishnaswamy, 2014, Expression and integrity of dermatopontin in chronic cutaneous wounds: a crucial factor in impaired wound healing, Cell Tissue Res., 358, 833, 10.1007/s00441-014-2000-z · DOI
  43. Robson, 1997, The role of growth factors in the healing of chronic wounds, Wound Repair Regen., 5, 12, 10.1046/j.1524-475X.1997.50106.x · DOI · Paper page
  44. Gaffney, 2015, Multilevel regulation of matrix metalloproteinases in tissue homeostasis indicates their molecular specificity in vivo, Matrix Biol., 44–46, 191, 10.1016/j.matbio.2015.01.012 · DOI
  45. Santala, 1999, Activation of interstitial collagenase, MMP-1, by Staphylococcus aureus cells having surface-bound plasmin: a novel role of plasminogen receptors of bacteria, FEBS Lett., 461, 153, 10.1016/S0014-5793(99)01440-4 · doi:10.1016/s0014-5793(99)01440-4
  46. Calander, 2006, Matrix metalloproteinase-9 (gelatinase B) deficiency leads to increased severity of Staphylococcus aureus-triggered septic arthritis, Microbes Infect., 8, 1434, 10.1016/j.micinf.2006.01.001 · DOI
  47. Schmidtchen, 2003, Elastase-producing Pseudomonas aeruginosa degrade plasma proteins and extracellular products of human skin and fibroblasts, and inhibit fibroblast growth, Microb. Pathog., 34, 47, 10.1016/S0882-4010(02)00197-3 · DOI
  48. Okamoto, 1997, Activation of human matrix metalloproteinases by various bacterial proteinases, J. Biol. Chem., 272, 6059, 10.1074/jbc.272.9.6059 · DOI · Paper page
  49. Min, 2002, Activation of macrophage promatrix metalloproteinase-9 by lipopolysaccharide-associated proteinases, J. Immunol., 168, 2449, 10.4049/jimmunol.168.5.2449 · DOI
  50. DeCarlo, 1997, Activation and novel processing of matrix metalloproteinases by a thiol-proteinase from the oral anaerobe Porphyromonas gingivalis, J. Dent. Res., 76, 1260, 10.1177/00220345970760060501 · DOI
  51. Oggioni, 2003, Pneumococcal zinc metalloproteinase ZmpC cleaves human matrix metalloproteinase 9 and is a virulence factor in experimental pneumonia, Mol. Microbiol., 49, 795, 10.1046/j.1365-2958.2003.03596.x · DOI
  52. Serra, 2016, Extracellular matrix assessment of infected chronic venous leg ulcers: role of metalloproteinases and inflammatory cytokines, Int. Wound J., 13, 53, 10.1111/iwj.12225 · DOI
  53. Martins, 2013, Matrix metalloproteinases and epidermal wound repair, Cell Tissue Res., 351, 255, 10.1007/s00441-012-1410-z · DOI · Paper page
  54. Parks, 1999, Matrix metalloproteinases in repair, Wound Repair Regen., 7, 423, 10.1046/j.1524-475X.1999.00423.x · DOI · Paper page
  55. McCawley, 2001, Matrix metalloproteinases: they're not just for matrix anymore!, Curr. Opin. Cell Biol., 13, 534, 10.1016/S0955-0674(00)00248-9 · DOI · Paper page
  56. Sudbeck, 1997, Induction and repression of collagenase-1 by keratinocytes is controlled by distinct components of different extracellular matrix compartments, J. Biol. Chem., 272, 22103, 10.1074/jbc.272.35.22103 · DOI
  57. Vaalamo, 1997, Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds, J. Investig. Dermatol., 109, 96, 10.1111/1523-1747.ep12276722 · DOI · Paper page
  58. Muller, 2008, Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing, Diabet. Med., 25, 419, 10.1111/j.1464-5491.2008.02414.x · DOI · Paper page
  59. Herouy, 1999, Lipodermatosclerosis and the significance of proteolytic remodeling in the pathogenesis of venous ulceration (review), Int. J. Mol. Med., 3, 511
  60. Herouy, 1998, Lipodermatosclerosis is characterized by elevated expression and activation of matrix metalloproteinases: implications for venous ulcer formation, J. Investig. Dermatol., 111, 822, 10.1046/j.1523-1747.1998.00369.x · DOI
  61. Percival, 2016, Antiseptics for treating infected wounds: efficacy on biofilms and effect of pH, Crit. Rev. Microbiol., 42, 293
  62. Harris, 1995, Cytokine and protease levels in healing and non-healing chronic venous leg ulcers, Exp. Dermatol., 4, 342, 10.1111/j.1600-0625.1995.tb00058.x · DOI
  63. Amato, 2015, Role of matrix metalloproteinases in non-healing venous ulcers, Int. Wound J., 12, 641, 10.1111/iwj.12181 · DOI
  64. Gao, 2015, Acceleration of diabetic wound healing using a novel protease-anti-protease combination therapy, Proc. Natl. Acad. Sci. U. S. A., 112, 15226, 10.1073/pnas.1517847112 · DOI · Paper page
  65. Nagase, 1999, Matrix metalloproteinases, J. Biol. Chem., 274, 21491, 10.1074/jbc.274.31.21491 · DOI · Paper page
  66. Vu, 2000, Matrix metalloproteinases: effectors of development and normal physiology, Genes Dev., 14, 2123, 10.1101/gad.815400 · DOI · Paper page
  67. Krishnaswamy, 2017, Dermatopontin augments angiogenesis and modulates the expression of transforming growth factor beta 1 and integrin alpha 3 beta 1 in endothelial cells, Eur. J. Cell Biol., 10.1016/j.ejcb.2017.02.007 · DOI
  68. Serra, 2016, Hemorrhoids and matrix metalloproteinases: a multicenter study on the predictive role of biomarkers, Surgery, 159, 487, 10.1016/j.surg.2015.07.003 · DOI
  69. de Franciscis, 2013, Increased plasma levels of metalloproteinase-9 and neutrophil gelatinase–associated lipocalin in a Rare case of multiple artery aneurysm, Ann. Vasc. Surg., 27, 1185, 10.1016/j.avsg.2013.01.011 · doi:10.1016/j.avsg.2013.01.011
  70. Serra, 2013, Chronic venous leg ulcers are associated with high levels of metalloproteinases-9 and neutrophil gelatinase-associated lipocalin, Wound Repair Regen., 21, 395, 10.1111/wrr.12035 · DOI
  71. Abdollahi, 2017, Insulin treatment prevents wounding associated changes in tissue and circulating neutrophil MMP-9 and NGAL in diabetic rats, PLoS One, 12, e0170951, 10.1371/journal.pone.0170951 · DOI
  72. Krampert, 2004, Activities of the matrix metalloproteinase stromelysin-2 (MMP-10) in matrix degradation and keratinocyte organization in wounded skin, Mol. Biol. Cell, 15, 5242, 10.1091/mbc.e04-02-0109 · DOI
  73. Bullard, 1999, Impaired wound contraction in stromelysin-1–deficient mice, Ann. Surg., 230, 260, 10.1097/00000658-199908000-00017 · DOI · Paper page
  74. Chen, 2009, MMP7 shedding of syndecan-1 facilitates re-epithelialization by affecting alpha(2)beta(1) integrin activation, PLoS One, 4, e6565, 10.1371/journal.pone.0006565 · DOI
  75. Mirastschijski, 2002, Ectopic localization of matrix metalloproteinase-9 in chronic cutaneous wounds, Hum. Pathol., 33, 355, 10.1053/hupa.2002.32221 · DOI
  76. Shapiro, 1993, Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages, J. Biol. Chem., 268, 23824, 10.1016/S0021-9258(20)80459-1 · DOI · Paper page
  77. Vaalamo, 1999, Enhanced expression of human metalloelastase (MMP-12) in cutaneous granulomas and macrophage migration, J. Investig. Dermatol., 112, 499, 10.1046/j.1523-1747.1999.00547.x · DOI
  78. Schafer, 2007, Transcriptional control of wound repair, Annu. Rev. Cell Dev. Biol., 23, 69, 10.1146/annurev.cellbio.23.090506.123609 · DOI · Paper page
  79. Yan, 2007, Regulation of matrix metalloproteinase gene expression, J. Cell. Physiol., 211, 19, 10.1002/jcp.20948 · DOI · Paper page
  80. Philipp, 2004, Targeting TGF-beta in human keratinocytes and its potential role in wound healing, Int. J. Mol. Med., 14, 589
  81. Ramirez, 2014, The role of TGFbeta signaling in wound epithelialization, Adv. Wound Care, 3, 482, 10.1089/wound.2013.0466 · DOI · Paper page
  82. Hasan, 1997, Dermal fibroblasts from venous ulcers are unresponsive to the action of transforming growth factor-beta 1, J. Dermatol. Sci., 16, 59, 10.1016/S0923-1811(97)00622-1 · DOI
  83. Kim, 2003, Fibroblasts from chronic wounds show altered TGF-β-signaling and decreased TGF-β Type II Receptor expression, J. Cell. Physiol., 195, 331, 10.1002/jcp.10301 · DOI · Paper page
  84. Han, 2001, Transforming growth factor-beta - and tumor necrosis factor-alpha -mediated induction and proteolytic activation of MMP-9 in human skin, J. Biol. Chem., 276, 22341, 10.1074/jbc.M010839200 · DOI · Paper page
  85. Philipp, 2005, TGF-beta antisense oligonucleotides reduce mRNA expression of matrix metalloproteinases in cultured wound-healing-related cells, Int. J. Mol. Med., 15, 299
  86. Riedel, 2008, TGF-beta antisense oligonucleotides modulate expression of matrix metalloproteinases in isolated fibroblasts from radiated skin, In Vivo, 22, 1
  87. Ponugoti, 2013, FOXO1 promotes wound healing through the up-regulation of TGF-beta1 and prevention of oxidative stress, J. Cell Biol., 203, 327, 10.1083/jcb.201305074 · DOI · Paper page
  88. Cheon, 2006, Beta-catenin regulates wound size and mediates the effect of TGF-beta in cutaneous healing, FASEB J., 20, 692, 10.1096/fj.05-4759com · DOI · Paper page
  89. Zhang, 2009, Effect of Wnt signaling pathway on wound healing, Biochem. Biophys. Res. Commun., 378, 149, 10.1016/j.bbrc.2008.11.011 · DOI
  90. Graves, 2014, Pyk2 contributes to reepithelialization by promoting MMP expression. Focus on “delayed skin wound repair in proline-rich protein tyrosine kinase 2 knockout mice”, Am. J. Physiol. Cell Physiol., 306, C887, 10.1152/ajpcell.00098.2014 · DOI
  91. Koppel, 2014, Delayed skin wound repair in proline-rich protein tyrosine kinase 2 knockout mice, Am. J. Physiol. Cell Physiol., 306, C899, 10.1152/ajpcell.00331.2013 · DOI
  92. Steckelings, 2004, Human skin: source of and target organ for angiotensin II, Exp. Dermatol., 13, 148, 10.1111/j.0906-6705.2004.0139.x · DOI
  93. Hao, 2011, Activation of skin renin-angiotensin system in diabetic rats, Endocrine, 39, 242, 10.1007/s12020-010-9428-z · DOI
  94. Ren, 2013, Angiotensin II regulates collagen metabolism through modulating tissue inhibitor of metalloproteinase-1 in diabetic skin tissues, Diab. Vasc. Dis. Res., 10, 426, 10.1177/1479164113485461 · doi:10.1177/1479164113485461
  95. Takeda, 2004, Effects of angiotensin II receptor signaling during skin wound healing, Am. J. Pathol., 165, 1653, 10.1016/S0002-9440(10)63422-0 · DOI
  96. Arenas, 2004, Angiotensin II-induced MMP-2 release from endothelial cells is mediated by TNF-alpha, Am. J. Physiol. Cell Physiol., 286, C779, 10.1152/ajpcell.00398.2003 · DOI
  97. Guo, 2008, Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells, Regul. Pept., 147, 37, 10.1016/j.regpep.2007.12.005 · DOI
  98. Wu, 2016, Src promotes cutaneous wound healing by regulating MMP-2 through the ERK pathway, Int. J. Mol. Med., 37, 639, 10.3892/ijmm.2016.2472 · DOI
  99. Cheng, 2007, Recombinant human platelet-derived growth factor enhanced dermal wound healing by a pathway involving ERK and c-fos in diabetic rats, J. Dermatol. Sci., 45, 193, 10.1016/j.jdermsci.2006.11.014 · DOI
  100. Lima, 2012, Topical insulin accelerates wound healing in diabetes by enhancing the AKT and ERK pathways: a double-blind placebo-controlled clinical trial, PLoS One, 7, e36974, 10.1371/journal.pone.0036974 · DOI · Paper page
  101. Agren, 1992, Collagenase in wound healing: effect of wound age and type, J. Investig. Dermatol., 99, 709, 10.1111/1523-1747.ep12614202 · DOI
  102. Pilcher, 1998, Collagenase-1 and collagen in epidermal repair, Arch. Dermatol. Res., 290, S37, 10.1007/PL00007452 · DOI
  103. Pilcher, 1999, Role of matrix metalloproteinases and their inhibition in cutaneous wound healing and allergic contact hypersensitivity, Ann. N. Y. Acad. Sci., 878, 12, 10.1111/j.1749-6632.1999.tb07671.x · DOI · Paper page
  104. Agren, 2001, Topical synthetic inhibitor of matrix metalloproteinases delays epidermal regeneration of human wounds, Exp. Dermatol., 10, 337, 10.1034/j.1600-0625.2001.100506.x · DOI
  105. Levin, 2017, Next generation matrix metalloproteinase inhibitors - novel strategies bring new prospects, Biochim. Biophys. Acta, 10.1016/j.bbamcr.2017.06.009 · DOI · Paper page
  106. Garrido-Mesa, 2013, What is behind the non-antibiotic properties of minocycline?, Pharmacol. Res., 67, 18, 10.1016/j.phrs.2012.10.006 · DOI · Paper page
  107. Xu, 2017, The effect of a common antibiotics doxycycline on non-healing chronic wound, Curr. Pharm. Biotechnol., 10.2174/1389201018666170519095339 · doi:10.2174/1389201018666170519095339
  108. Stechmiller, 2010, The role of doxycycline as a matrix metalloproteinase inhibitor for the treatment of chronic wounds, Biol. Res. Nurs., 11, 336, 10.1177/1099800409346333 · DOI
  109. Sung, 2010, Gel characterisation and in vivo evaluation of minocycline-loaded wound dressing with enhanced wound healing using polyvinyl alcohol and chitosan, Int. J. Pharm., 392, 232, 10.1016/j.ijpharm.2010.03.024 · DOI · Paper page
  110. Mirastschijski, 2004, Matrix metalloproteinase inhibitor GM 6001 attenuates keratinocyte migration, contraction and myofibroblast formation in skin wounds, Exp. Cell Res., 299, 465, 10.1016/j.yexcr.2004.06.007 · DOI
  111. Mirastschijski, 2010, Matrix metalloproteinase inhibition delays wound healing and blocks the latent transforming growth factor-beta1-promoted myofibroblast formation and function, Wound Repair Regen., 18, 223, 10.1111/j.1524-475X.2010.00574.x · DOI
  112. Natchus, 2001, Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines, J. Med. Chem., 44, 1060, 10.1021/jm000477l · doi:10.1021/jm000477l
  113. Fields, 2015, New strategies for targeting matrix metalloproteinases, Matrix Biol., 44-46, 239, 10.1016/j.matbio.2015.01.002 · DOI · Paper page
  114. Brett, 2008, A Review of Collagen and Collagen-based Wound Dressings, Wounds, 20, 347
  115. Omolu, 2017, Assessment of solid microneedle rollers to enhance transmembrane delivery of doxycycline and inhibition of MMP activity, Drug Deliv., 24, 942, 10.1080/10717544.2017.1337826 · DOI
  116. Korrapati, 2016, Recent advancements in nanotechnological strategies in selection, design and delivery of biomolecules for skin regeneration, Mater. Sci. Eng. C Mater. Biol. Appl., 67, 747, 10.1016/j.msec.2016.05.074 · DOI · Paper page

Cited by

See all 183

Metadata

Authors
Krishnaswamy, V. R., Mintz, D., & Sagi, I.
Venue
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Publisher
Elsevier BV
Published
2017-11
Volume
1864
Issue
11
Pages
2220-2227
ISSN
0167-4889 (ISSN-L)
OpenAlex
W2742501995
Cited by
183
References
11
FWCI
9.45
Type
journal article
Language
en
Open access
bronze
Licence
Funders
  • Israeli Science Foundation (1226/13)
  • European Research Council AdG (DLV-695437)
  • USA–Israel Binational Science Foundation (712506-01)
  • Minerva Foundation (712592-01)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.